-+ 0.00%
-+ 0.00%
-+ 0.00%

Craig-Hallum Initiates Coverage On Opus Genetics with Buy Rating, Announces Price Target of $6

Benzinga·04/11/2025 17:43:02
Listen to the news
Craig-Hallum analyst Albert Lowe initiates coverage on Opus Genetics (NASDAQ:IRD) with a Buy rating and announces Price Target of $6.